
Lebrikizumab effective against moderate-to-severe atopic dermatitis, trials find
March 24, 2023 2 min read Source/Disclosures Disclosures: Silverberg reports consulting for AbbVie, AnaptysBio, Arcutis, Arena Pharmaceuticals, Asana, Aslan, BioMX, Biosion, Boehringer Ingelheim, Cara, Celgene, Connect Biopharma, Dermavant, Demira, Eli …